[Active specific immune therapy of prostate gland cancer].
Chakŭrov
S
S
Minchev
M
M
D000954:Antigens, Surface; D002268:Carboxypeptidases / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D043425:Glutamate Carboxypeptidase II; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000276:immunology / Q000628:therapy*; D019444:Vaccines, DNA / Q000276:immunology / Q000627:therapeutic use
D000954:Antigens, Surface; D019444:Vaccines, DNA; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002268:Carboxypeptidases; C473848:FOLH1 protein, human; D043425:Glutamate Carboxypeptidase II